Ruey‐Long Hong

10.8k total citations
121 papers, 3.2k citations indexed

About

Ruey‐Long Hong is a scholar working on Oncology, Otorhinolaryngology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ruey‐Long Hong has authored 121 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Oncology, 39 papers in Otorhinolaryngology and 37 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ruey‐Long Hong's work include Head and Neck Cancer Studies (39 papers), Cancer Immunotherapy and Biomarkers (17 papers) and Lung Cancer Treatments and Mutations (16 papers). Ruey‐Long Hong is often cited by papers focused on Head and Neck Cancer Studies (39 papers), Cancer Immunotherapy and Biomarkers (17 papers) and Lung Cancer Treatments and Mutations (16 papers). Ruey‐Long Hong collaborates with scholars based in Taiwan, United States and Japan. Ruey‐Long Hong's co-authors include Jun‐Jen Liu, Yun-Long Tseng, Yun‐Long Tseng, Lai‐Lei Ting, Pei‐Jen Lou, Jenq‐Yuh Ko, Ruoh‐Fang Yen, Joseph Tung‐Chieh Chang, Anthony T.�C. Chan and Tsang-Wu Liu and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Ruey‐Long Hong

118 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruey‐Long Hong Taiwan 34 1.5k 938 878 847 808 121 3.2k
Jonathan D. Schoenfeld United States 32 2.6k 1.7× 660 0.7× 735 0.8× 644 0.8× 1.2k 1.5× 139 4.1k
Kunyu Yang China 36 1.7k 1.1× 583 0.6× 528 0.6× 1.5k 1.7× 1.5k 1.9× 173 4.6k
Gordon B. Snow Netherlands 43 2.5k 1.6× 2.4k 2.6× 1.9k 2.2× 1.2k 1.5× 1.4k 1.8× 127 6.3k
J.C. Grecula United States 31 978 0.6× 363 0.4× 508 0.6× 430 0.5× 1.0k 1.3× 159 2.8k
Michael T. Spiotto United States 27 1.6k 1.0× 439 0.5× 423 0.5× 763 0.9× 926 1.1× 99 3.8k
Missak Haigentz United States 37 1.8k 1.2× 1.7k 1.8× 1.6k 1.8× 736 0.9× 903 1.1× 121 3.8k
I. Bing Tan Netherlands 30 957 0.6× 847 0.9× 773 0.9× 308 0.4× 961 1.2× 76 2.5k
Christopher Milross Australia 27 971 0.6× 726 0.8× 560 0.6× 480 0.6× 520 0.6× 55 2.5k
Regina Gandour‐Edwards United States 34 929 0.6× 306 0.3× 856 1.0× 1.1k 1.3× 918 1.1× 122 3.3k
Lisle M. Nabell United States 23 726 0.5× 413 0.4× 307 0.3× 603 0.7× 487 0.6× 57 1.9k

Countries citing papers authored by Ruey‐Long Hong

Since Specialization
Citations

This map shows the geographic impact of Ruey‐Long Hong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruey‐Long Hong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruey‐Long Hong more than expected).

Fields of papers citing papers by Ruey‐Long Hong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruey‐Long Hong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruey‐Long Hong. The network helps show where Ruey‐Long Hong may publish in the future.

Co-authorship network of co-authors of Ruey‐Long Hong

This figure shows the co-authorship network connecting the top 25 collaborators of Ruey‐Long Hong. A scholar is included among the top collaborators of Ruey‐Long Hong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruey‐Long Hong. Ruey‐Long Hong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cho, Byoung Chul, Irene Braña, Beatriz Cirauqui, et al.. (2024). Pembrolizumab plus epacadostat in patients with recurrent/metastatic head and neck squamous cell carcinoma (KEYNOTE-669/ECHO-304): a phase 3, randomized, open-label study. BMC Cancer. 23(S1). 1254–1254. 5 indexed citations
2.
Razak, Albiruni Ryan Abdul, Hung‐Ming Wang, Jang‐Yang Chang, et al.. (2023). A Phase 1b/2 Study of Alpelisib in Combination with Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma. Targeted Oncology. 18(6). 853–868. 10 indexed citations
3.
Lim, Wan‐Teck, Hsiang‐Fong Kao, Lisda Suteja, et al.. (2023). Clinical efficacy and biomarker analysis of dual PD-1/CTLA-4 blockade in recurrent/metastatic EBV-associated nasopharyngeal carcinoma. Nature Communications. 14(1). 2781–2781. 25 indexed citations
4.
Ma, Weili, Ruey‐Long Hong, Pei‐Jen Lou, et al.. (2023). Improved outcomes of localized diffuse large B‐cell lymphoma at the Waldeyer ring in comparison to the sinonasal area in the rituximab era. Cancer Medicine. 13(1). e6851–e6851. 1 indexed citations
5.
Chen, Tom Wei‐Wu, Chia‐Lang Hsu, Ruey‐Long Hong, et al.. (2022). A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma. Clinical Cancer Research. 28(23). 5058–5065. 9 indexed citations
6.
Kao, Hsiang‐Fong, Bin-Chi Liao, Yenlin Huang, et al.. (2022). Afatinib and Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (ALPHA Study): A Phase II Study with Biomarker Analysis. Clinical Cancer Research. 28(8). 1560–1571. 53 indexed citations
7.
Chen, Chih‐Wei, Ming‐Hsiao Hu, Jen‐Chieh Lee, et al.. (2019). Primary intradural extramedullary spinal mesenchymal chondrosarcoma: case report and literature review. BMC Musculoskeletal Disorders. 20(1). 408–408. 9 indexed citations
8.
Lizotte, Patrick H., Ruey‐Long Hong, Troy A. Luster, et al.. (2018). A High-Throughput Immune-Oncology Screen Identifies EGFR Inhibitors as Potent Enhancers of Antigen-Specific Cytotoxic T-lymphocyte Tumor Cell Killing. Cancer Immunology Research. 6(12). 1511–1523. 69 indexed citations
9.
Liu, Chia‐Wen, Kuo‐Tai Hua, Kaichun Li, et al.. (2017). Histone Methyltransferase G9a Drives Chemotherapy Resistance by Regulating the Glutamate–Cysteine Ligase Catalytic Subunit in Head and Neck Squamous Cell Carcinoma. Molecular Cancer Therapeutics. 16(7). 1421–1434. 48 indexed citations
10.
11.
Hong, Ruey‐Long, et al.. (2015). Nasopharyngeal Carcinoma and Pulmonary Lymphoepithelioma-like Carcinoma – Metastases or Synchronous Second Primary Cancer. SHILAP Revista de lepidopterología. 1 indexed citations
12.
Lin, Yu‐Chin, et al.. (2012). Clinicopathological features of salivary and non-salivary adenoid cystic carcinomas. International Journal of Oral and Maxillofacial Surgery. 41(3). 354–360. 20 indexed citations
13.
Wy, Chen, Sung‐Hsin Kuo, Yu‐Hsuan Chen, et al.. (2011). Postoperative Intensity-Modulated Radiotherapy for Squamous Cell Carcinoma of the External Auditory Canal and Middle Ear: Treatment Outcomes, Marginal Misses, and Perspective on Target Delineation. International Journal of Radiation Oncology*Biology*Physics. 82(4). 1485–1493. 11 indexed citations
14.
Li, Chi‐Cheng, Hwei‐Fang Tien, Jih‐Luh Tang, et al.. (2004). Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer/T‐cell or T‐cell lymphoma. Cancer. 100(2). 366–375. 141 indexed citations
15.
Hong, Ruey‐Long. (2004). Liposomal Anti-Cancer Drug Researches-The Myth of Long Circulation. 20(2). 10–21. 5 indexed citations
16.
Hong, Ruey‐Long & Yun‐Long Tseng. (2001). Phase I and pharmacokinetic study of a stable, polyethylene-glycolated liposomal doxorubicin in patients with solid tumors. Cancer. 91(9). 1826–1833. 69 indexed citations
17.
Hong, Ruey‐Long, Darrick S. H. L. Kim, Chieh‐Fu Chen, et al.. (1998). Tyrosine kinase inhibitors, emodin and its derivative repress HER-2/neu-induced cellular transformation and metastasis-associated properties. Oncogene. 16(22). 2855–2863. 106 indexed citations
18.
19.
Ij, Su, et al.. (1991). Peripheral T cell lymphoma containing Reed-Sternberg or RS-like giant cell (Hodgkin-like PTL): An aggressive disease morphologically mimicking Hodgkin's disease but with distinct clinical features. 7. 9–20. 2 indexed citations
20.
Pm, Sondel, et al.. (1987). Clinical testing of IL-2: in vivo administration of IL-2 induces IL-2 dependent non-MHC-restricted cytotoxicity (NRC).. PubMed. 244. 173–84. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jonathan D. Schoenfeld Breakdown of academic impact, for papers by Kunyu Yang Breakdown of academic impact, for papers by Gordon B. Snow Breakdown of academic impact, for papers by J.C. Grecula Breakdown of academic impact, for papers by Michael T. Spiotto Breakdown of academic impact, for papers by Missak Haigentz Breakdown of academic impact, for papers by I. Bing Tan Breakdown of academic impact, for papers by Christopher Milross Breakdown of academic impact, for papers by Regina Gandour‐Edwards Breakdown of academic impact, for papers by Lisle M. Nabell
Rankless by CCL
2026